Evofem Biosciences, Inc. Made Headway
Fri, Jun 23, 2023 at 07:36 PM
Evofem Biosciences, Inc. (EVFM:NASDAQ) shot up at $0.9, a gain of 28.6%. The stock appeared on our News Catalysts scanner on Fri, Jun 16, 2023 at 06:41 PM in the 'EARNINGS' category. From Fri, Jun 09, 2023, the stock recorded 44.44% Up Days and 70.00% Green Days
About Evofem Biosciences, Inc. (EVFM:NASDAQ)
Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.
Top 10 Gainers:
- Kidpik Corp. (PIK:NASDAQ), 101.72%
- Conformis, Inc. (CFMS:NASDAQ), 87.07%
- Lulu's Fashion Lounge Holdings Inc. (LVLU:NASDAQ), 48.11%
- SCWorx Corp. (WORX:NASDAQ), 45.46%
- Peak Bio Inc Com (PKBO:NASDAQ), 42.14%
- Surgalign Holdings Inc. (SRGA:NASDAQ), 38.81%
- OncoSec Medical Incorporated (ONCS:NASDAQ), 31.87%
- AdTheorent Holding Company Inc. (ADTH:NASDAQ), 31.58%
- Etao International Co. Ltd. (ETAO:NASDAQ), 30.39%
- Evofem Biosciences, Inc. (EVFM:NASDAQ), 28.57%